Health Technology Report Names Nym’s Melisa Tucker One of 2022’s “Top 25 Women Leaders in Health Software”
NEW YORK–(BUSINESS WIRE)–Nym Health, a leader in turning clinical language into actionable insights, today announced that its Senior Vice President and Chief Product Officer, Melisa Tucker, has been named one of the “Top 25 Women Leaders in healthcare software” of 2022 by The Healthcare Technology Report. The annual list recognizes women in leadership roles who have made significant contributions to the growth of their organizations, while playing a critical role in developing software products and services that help transform healthcare for patients and providers.
Tucker oversees Nym’s products, customer success, and coding compliance organizations. She is responsible for further developing the company’s product vision, roadmap and innovation strategy to fuel future growth and drive rapid adoption of Nym’s medical coding engine, which is arming hospitals, health systems and other healthcare providers with technology to instantly interpret clinical language and automate cumbersome and costly administrative procedures.
“Our goal is to deliver a solution that fuels automation and dramatically reduces administrative complexity, allowing healthcare providers to spend more time on patient care while optimizing their revenue cycles to ensure business continuity and long-term financial stability,” said Amihai Niederman, CEO and co-founder of Nym. “We are delighted that the Health Technology Report has recognized Melisa for her outstanding contributions to Nym, our customers, and the healthcare processes we are all working to transform to improve patient care.”
Tucker joined Nym from Flatiron Health (acquired by Roche in 2018), where she served as vice president of product management and operations. She led the growth of Flatiron’s real-world proof business from inception to industry leader, launching and developing multiple product lines in collaboration with key business and strategic partners. Prior to Flatiron, Melisa worked in management consulting at McKinsey & Company and in early stage venture capital.
“It is an honor to be included alongside this esteemed group of leaders from across the healthcare industry and to be part of Nym’s interdisciplinary team of specialists, which includes world-class technologists , physicians, mathematicians, computer linguists, engineers and medical coders, among other experts,” Tucker said. “I share this recognition with the Nym team and am inspired by our mission-driven commitment to create tools that allow healthcare providers to instantly interpret clinical language and use this actionable information to provide better patient care.”
Selected from hundreds of nominees for this year’s “Top 25 Women Leaders in Healthcare Software”, the 2022 winners represent companies that provide solutions in a wide range of areas, from connected care to clinical software, ambulatory practices, cost control and more. Healthcare Technology Report staff evaluated each submission based on recommendations from the nominees’ peers and colleagues, as well as a detailed review of leadership roles, longevity in the field, technical expertise and sense of purpose. business, among other factors.
About the Health Technology Report
The Health Technology report provides market research and insights, business news, investment activity updates, and important company developments related to the Health Technology industry. Based in New York, the company is led by a seasoned team of editors, writers and media professionals with deep knowledge of health technologies and the various companies, executives and investors that make up the industry.
Nym Health is the leader in turning clinical language into actionable information, which can eliminate the inefficiencies that add billions to the cost of care. By combining state-of-the-art technology with clinical expertise and a deep understanding of medical language, Nym is able to accurately decode medical records in a fast, explainable and compliant manner. The company’s innovative solution for Revenue Cycle Management (RCM) takes provider notes from patient records and translates them into accurate diagnostic and billing codes, all in seconds and without human intervention. With over 96% accuracy, Nym’s RCM solution provides traceable, audit-ready documentation for every code it generates, ensuring full visibility into why each code was assigned. The Nym solution can be quickly deployed and scaled based on volume and workflow needs, easing administrative burdens and allowing clinical teams to spend more time on patient care.
Based in New York with R&D capabilities in Tel Aviv, Nym builds an interdisciplinary team of specialists including technologists, physicians, mathematicians, computational linguists, engineers, medical coders and more. Nym investors include Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, Lightspeed, Tiger Global, Zach Weinberg and Nat Turner. To learn more about Nym, visit nym.health.